The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial

Yu. A. Karpov

Rational Pharmacotherapy in Cardiology
Rational Pharmacotherapy in Cardiology

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

User

eng | рус

Rational Pharmacotherapy in Cardiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Karpov Yu.A. The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial. Rational Pharmacotherapy in Cardiology. 2018;14(6):922-934. https://doi.org/10.20996/1819-6446-2018-14-6-922-934

Views PDF (Eng): 2317

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Username
Password
	Remember me

User

Rational Pharmacotherapy in Cardiology

For citations:

Cookies policy